SWEENY NICOLE (Chief Commercial Officer) sold 7.8% of their position (3.98K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $61.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001827505-26-000002
Officer· Chief Commercial Officer
Since Feb 2026
-3.98K
Net shares
Net seller
$61.9K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
11.25K acquired · 15.22K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
15.7%
2/21/2026
39.73K→45.98K
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
10.9%
2/22/2026
45.98K→50.98K
Common Stock
Direct
Shares
−3.98K
Price / share
$15.57
Trade value
$61.88K
% of position
7.8%
2/23/2026
50.98K→47K
Total
Net shares
+7.28K
Net value
-$61.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2026 | M · Option Exercise | +6.25K | — | — | 15.7% | 39.73K | 45.98K |
| Common Stock Direct | 2/22/2026 | M · Option Exercise | +5K | — | — | 10.9% | 45.98K | 50.98K |
| Common Stock Direct | 2/23/2026 | S · Sale | −3.98K | $15.57 | $61.88K | 7.8% | 50.98K | 47K |
| Total | +7.28K | -$61.88K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
75K
Exercisable
—
2/21/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
45K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 2/21/2026 | M · Option Exercise | −6.25K | — | 75K | |
| Restricted Stock Unit Direct | Common Stock5K shares | 2/22/2026 | M · Option Exercise | −5K | — | 45K |